Canadian Pacific

The Montreal Heart Institute Foundation is proud to announce a donation of $ 50,000 from Canadian Pacific (CP) as part of its CP Has Heart campaign to acquire a DNA sequencer. This state-of-the-art device will, among other things, optimize the treatment of patients with COVID-19.

The NovaSeq 6000 DNA sequencer is a robotic device that will allow researchers at the Beaulieu-Saucier Pharmacogenomics Center of Université de Montréal at the Montreal Heart Institute, to study the genetics of patients with COVID-19 to better understand the disease and its symptoms.